These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31907188)

  • 21. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and
    Kumar S; Shah P; Tripathi SK; Khan SI; Singh IP
    Med Chem; 2022; 18(9):949-969. PubMed ID: 35240963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Characterization and Antifungal Evaluation of Novel Thiochromanone Derivatives Containing Indole Skeleton.
    Han XY; Zhong YF; Li SB; Liang GC; Zhou G; Wang XK; Chen BH; Song YL
    Chem Pharm Bull (Tokyo); 2016 Sep; 64(9):1411-6. PubMed ID: 27373770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
    Del Poeta M; Bixel AS; Barchiesi F; Tidwell RR; Boykin D; Scalise G; Perfect JR
    J Antimicrob Chemother; 1999 Aug; 44(2):223-8. PubMed ID: 10473229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of the Pandemic Response Box Reveals an Association between Antifungal Effects of MMV1593537 and the Cell Wall of
    de Oliveira HC; Castelli RF; Reis FCG; Samby K; Nosanchuk JD; Alves LR; Rodrigues ML
    Microbiol Spectr; 2022 Jun; 10(3):e0060122. PubMed ID: 35471056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
    Fromtling RA; Yu HP; Shadomy S
    Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flucytosine primary resistance in Candida species and Cryptococcus neoformans.
    Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Rodríguez-Tudela JL
    Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):276-9. PubMed ID: 11399020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
    Pfaller MA; Messer SA; Boyken L; Hollis RJ; Rice C; Tendolkar S; Diekema DJ
    Diagn Microbiol Infect Dis; 2004 Mar; 48(3):201-5. PubMed ID: 15023430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.
    Al Jalali V; Sauermann R; Eberl S; Zeitlinger M
    Infection; 2019 Aug; 47(4):565-570. PubMed ID: 30725316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Nitrostyrene derivatives as broad range potential antifungal agents targeting fungal cell wall.
    Ramzan A; Padder SA; Masoodi KZ; Shafi S; Tahir I; Rehman RU; Prasad R; Shah AH
    Eur J Med Chem; 2022 Oct; 240():114609. PubMed ID: 35932582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of novel semicarbazone-selenochroman-4-ones hybrids as potent antifungal agents.
    Xu H; Su X; Liu XQ; Zhang KP; Hou Z; Guo C
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126726. PubMed ID: 31615700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia.
    Seyoum E; Bitew A; Mihret A
    BMC Infect Dis; 2020 Mar; 20(1):231. PubMed ID: 32188422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and Biological Evaluation of Novel 2-Aminonicotinamide Derivatives as Antifungal Agents.
    Ni T; Li R; Xie F; Zhao J; Huang X; An M; Zang C; Cai Z; Zhang D; Jiang Y
    ChemMedChem; 2017 Feb; 12(4):319-326. PubMed ID: 28071858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility.
    Krysan DJ; Zhai B; Beattie SR; Misel KM; Wellington M; Lin X
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic antifungal activity of berberine derivative B-7b and fluconazole.
    Li LP; Liu W; Liu H; Zhu F; Zhang DZ; Shen H; Xu Z; Qi YP; Zhang SQ; Chen SM; He LJ; Cao XJ; Huang X; Zhang JD; Yan L; An MM; Jiang YY
    PLoS One; 2015; 10(5):e0126393. PubMed ID: 25992630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of four compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus.
    de Oliveira HC; Castelli RF; Alves LR; Nosanchuk JD; Salama EA; Seleem M; Rodrigues ML
    Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35575621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antifungal synergy between amphiphilic aminoglycoside K20 and azoles against Candida species and Cryptococcus neoformans.
    Shrestha SK; Grilley M; Anderson T; Dhiman C; Oblad J; Chang CW; Sorensen KN; Takemoto JY
    Med Mycol; 2015 Nov; 53(8):837-44. PubMed ID: 26260746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.